83 related articles for article (PubMed ID: 21176738)
1. Cross-resistance of 5-fluorouracil-resistant colon carcinoma in vitro.
Ratzenboeck IE; Bartl B; Forstner B; Kalipciyan M; Steger GG; Mader RM
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):81-2. PubMed ID: 21176738
[No Abstract] [Full Text] [Related]
2. Suicide activation in a 5-fluorouracil resistant colon cancer model in vitro.
Mader RM; Kalipciyan M; Ohana P; Hochberg A; Steger GG
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):69-70. PubMed ID: 21176733
[No Abstract] [Full Text] [Related]
3. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
4. Cimetidine enhances the antiproliferative effect of 5-fluorouracil on colon carcinoma SW620.
Komatsubara M; Nagata T; Miyauchi S; Kamo N
Anticancer Res; 1999; 19(2A):1153-7. PubMed ID: 10368668
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
[TBL] [Abstract][Full Text] [Related]
7. NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model.
Körber MI; Klingenbrunner S; Bartsch R; Steger GG; Mader RM
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):35-7. PubMed ID: 23259994
[No Abstract] [Full Text] [Related]
8. Proteomic analysis of chemoresistance to 5-fluorouracil in colon cancer in vitro.
Mader RM; Schmidt WM; Mitterer G; Gerner C
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):599-600. PubMed ID: 16372533
[No Abstract] [Full Text] [Related]
9. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
10. NFκB-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma.
Körber MI; Staribacher A; Ratzenböck I; Steger G; Mader RM
Anticancer Res; 2016 Apr; 36(4):1631-9. PubMed ID: 27069140
[TBL] [Abstract][Full Text] [Related]
11. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
13. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells.
Wu X; Deng Y; Wang G; Tao K
J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistance.
Schmidt WM; Kalipciyan M; Dornstauder E; Rizovski B; Sedivy R; Steger GG; Müller MW; Mader RM
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):624-5. PubMed ID: 14692722
[No Abstract] [Full Text] [Related]
15. Effectiveness of adjuvant fluorouracil in elderly colon cancer patients: the internal and external validity of nonrandomized research design.
Apolone G; Cavuto S; Torri V; la Vecchia C
J Clin Oncol; 2003 May; 21(9):1892; author reply 1893. PubMed ID: 12721271
[No Abstract] [Full Text] [Related]
16. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
17. Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil.
Wang S; El-Deiry WS
Cancer Res; 2004 Sep; 64(18):6666-72. PubMed ID: 15374982
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro.
Schönau KK; Steger GG; Mader RM
Cancer Lett; 2007 Nov; 257(1):73-8. PubMed ID: 17686575
[TBL] [Abstract][Full Text] [Related]
20. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
